Home › Funds › Wealth Intelligence, LLC › CVS
Wealth Intelligence, LLC position in CVS
CVS HEALTH CORP · Consumer Staples
Wealth Intelligence, LLC reported holding 25,424 shares of CVS (CVS HEALTH CORP) in its Q3 2026 13F filing — a position valued at US$2.2M, representing 1.04% of its reported portfolio and ranking #21 among its reported holdings. Wealth Intelligence, LLC has disclosed CVS holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-10-16 · Source: SEC EDGAR Form 13F-HR
How Wealth Intelligence, LLC's CVS position evolved
Wealth Intelligence, LLC first disclosed a stake in CVS in Q4 2025 at 25,984 shares (US$2.1M). The position peaked in Q2 2026 at 27,203 shares, worth US$2.8M. Across 4 filings, Wealth Intelligence, LLC increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 25,424 shares valued at US$2.2M — a reduction of -1,779 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 25.98K | $2.06M | New |
| Q1 2026 | 26.77K | $1.92M | Add |
| Q2 2026 | 27.20K | $2.81M | Add |
| Q3 2026 | 25.42K | $2.18M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CVS and 13F data
CVS (CVS HEALTH CORP) is a Consumer Staples company. 39 other funds we track also report a position in CVS — the largest reported positions include Capital World Investors (US$7.75B), Capital World Investors (US$7.75B), Dodge & Cox (US$5.17B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CVS
- Capital World Investors 74.95M sh · $7.75B · Q2 2026
- Capital World Investors 74.95M sh · $7.75B · Q2 2026
- Dodge & Cox 50.01M sh · $5.17B · Q2 2026
- DODGE & COX 50.01M sh · $5.17B · Q2 2026
- Wellington Management Group 33.80M sh · $3.50B · Q2 2026
- WELLINGTON MANAGEMENT GROUP LLP 33.80M sh · $3.50B · Q2 2026
- DAVIS SELECTED ADVISERS 11.87M sh · $1.23B · Q2 2026
- Pzena Investment Management 11.77M sh · $1.22B · Q2 2026
- Clearbridge Investments, LLC 8.54M sh · $883.12M · Q2 2026
- GQG Partners LLC 7.96M sh · $822.99M · Q2 2026
More on Wealth Intelligence, LLC
FAQ
How long has Wealth Intelligence, LLC held CVS?
Wealth Intelligence, LLC has disclosed CVS holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Wealth Intelligence, LLC's current position in CVS?
As of Q3 2026, Wealth Intelligence, LLC holds 25.42K shares of CVS (CVS HEALTH CORP), valued at $2.18M, representing 1.04% of its reported portfolio and ranking #21.
Has Wealth Intelligence, LLC been buying or selling CVS?
In the latest 13F filing (Q3 2026), Wealth Intelligence, LLC reduced its position in CVS. The position peaked in Q2 2026 at 27.20K shares.
Which other funds hold CVS?
Other major institutional holders of CVS include Capital World Investors, Capital World Investors, Dodge & Cox, among 39 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.